Integral Health Asset Management, LLC Seres Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $409,500 - $1.7 Million	-75,000 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$18.46 - $24.36 $1.38 Million - $1.83 Million	-75,000 Reduced 50.0%	75,000 $1.79 Million
Q2 2021 Aug 13, 2021	BUY	$18.46 - $24.36 $2.77 Million - $3.65 Million	150,000 New	150,000 $3.58 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $697,500 - $1.13 Million	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $112,200 - $862,200	30,000 New	30,000 $849,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.